By Author
  By Title
  By Keywords

April 1997, Volume 47, Issue 4

Case Reports

Mikulicz Syndrome

Aamer Aleem  ( Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, Riyadh, Saudi Arabia. )
Mohammad S. Harakati  ( Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, Riyadh, Saudi Arabia. )
Abdulkareem Al-Momen  ( Department of Medicine, Division of Hematology/Oncology, College of Medicine and King Khalid University Hospital, Riyadh, Saudi Arabia. )

Mikulicz syndrome is characterized by diffuse bilateral enlargement of lacrimal, parotid and other salivary glands. It can be secondary to many diseases like lymphoma, tuberculosis, leukemia, sarcoidosis and syphilis. We report a case of primary non-Hodgkin’s lymphomapresenting withthe features of Mikulicz syndrome. As this entity is controversial, literature is reviewed with particular emphasis on historical perspective and recent developments.

Case Report

A 13 years old girl presented with 3 weeks history of painless swellings in both parotid and submandibular regions accompanied by facial asymmetry. There was no history of fever, weight loss, night sweats or recent upper respiratory tract infection or contact with a person with tuberculosis or having similar complaints. Apart from mild headache there was no histoiy of neurological symptoms. The patient was admitted three months prior to this presentation when she was referred from a peripheral hospital for work-up of anaemia. Complete blood counts had revealed pancytopenia with a white cell count of 1.8x10 9/liter, hemoglobin 30 grams/liter with normal red cell indices and platelet count of35x109/liter. There was no history of recent viral illness or exposure to drugs. Physical examination was normal apart from severe pallor. Autoimmune screening and serological studies for hepatitis B and C were negative. Bone marrow examination had shown severely hypoplastic marrow, without evidence of infiltration. She received supportive treatment in the form of antibiotics, blood andplatelet transfusions and steroids. While inthe hospital, blood counts started to improve and white cells and platelets rose to normal level within a week while haemoglobin started to improve rather slowly. The cause of this transient bone marrow suppression was presumed to be viral in origin. She was discharged on tapering doses of steroids. Physical examination during the current admission revealed symmetrical enlargement of both parotid, submandibular and lacrimal glands with left lower motor neurone 7th nerve palsy (Figure 1).

There was no lymphadenopathy orhepatosplenomegaly, rest of the physical examination was normal. Initial investigations including complete blood count, liver function test, urea, creatinine, electrolytes, serum calcium, uric acid and chest x-ray were normal. There was a mild rise of alkaline phosphatase and serum lactate dehydrogenase above the normal value. Serology for hepatitis B, C, Epstein-Barr virus and HIV was negative as were antinuclear antibodies. A fme needle aspiration of the left parotid gland showed non-Hodgkin’s lymphoma. While still in hospital the patient developed multi-palpable cervical lymph nodes. So a biopsy was carried out and confirmed the diagnosis of non-Hodgkin’s lymphoma of diffuse large cell type (Figure 2).

Staging procedures including CT-scan of chest and abdomen, bone marmw biopsy and whole body Gallium scan did not reveal any evidence of lymphoma in the rest of the body. Cerebrespinal fluid examination and CT-scan of brain were also normal. The patient was started on CNOP chemotherapy consisting of Cyclophosphamide 750 mg/m2 intravenously (IV) 2. Mitoxantrone 10 mg/m2 IV, Oncovin(Vincristine) 1.4 mg/m2 IV and Prednisolone 100 rng per oral daily for 5 days, (each cycle repeated at 3 weekly intervals). The 1st cycle of chemotherapy was followed by complete resolution of swellings in the neck and face. The facial nerve palsy also resolved without any residual defect. Central nervous system (CNS) prophylaxis (intrathecal chemotherapy) was considered but it was refused by the patient and her parents. The patient achieved complete remission after 8 cycles of chemotherapy. Three months later she presented with severe headache and right upper motor neurone 7th nerve palsy. Cerebro-spinal fluid examination showed large number of lymphoma cells. CT-scan of brain was still normal. Intraventricular chemotherapy consisting of methotrexate 10 mg,cytosine arabinoside 50 mgandhydrocortisone 50 mgwas initiated thmugh Omayya reservoir. A total of 10 cycles of intraventricular chemotherapy were required to achieve CNS remission. She however, died few months later due to progressive systemic and CNS disease.

References

1. Mikulicz, J. Ueber eine Eligenartige symmetrischc. Erkrankung der Thranen Mundspeicheldrusen, Beitr 2. Chir Festschr TheodorBiliroth, 1892, pp. 610-630.
2. Mikulicz, 3. Concerning peculiar symmetrical disease of lacrimal and salivary glands. Medical Classics, 1937.1938;2:165-1 86.
3. Schaffer, J.T. and Jacobson, A.W. Mikulicz syndrome, a report often cases. Am. J. Dis. Child., 1927,34:327.
4. Godwin, J.T. Benign lymphoepithelial lesion of the parotid gland: Report of 11 cases. Cancer, 1952;5:1089-1 103.
5. Morgan, W.S. and Castleman, B. A clinicopathologic study of “Mikulicz’s disease’. Am, J.Pathol., 1953;29:471-89.
6. Awan, K.J. Mikulicz disease and Mikulicz syndrome. South Med. J., I 976;69:458-459.
7. Maclean, H. ,lronside, J.W., Culten, J.F. et al. Mikulicz syndrome and disease: 2 case reports highlighting the difference. Acts Opthalmol. (Copenh.), 1993;71: 136.41.
8. Penfold, C.N. Mikulicz syndrome. 3. Oral Maxillofac. Surg., 1985;43:900-5.
9. Takahashi, H., Cheng, 3., Fujita, S. et al. Primary malignant lymphoma of the salivary gland: A tumor ofmucosa associated lymphoid tissue. 3. Oral Pathol. Med., 1992;21 :318-25/
10. Evans, R.W. and Cruickshank, A.H. Mikulicz-Sjogren syndrome. In: Epi­thelial tumours of the salivary glands: Vol. 1 in the series, Bennington J.L. ed. Philadelphia, London, Toronto, W.B. Saunders company, 1970, pp. 279-295.
11. Isaacson, P.G. and Spencer, J. Malignant lymphoma and mucosa associated lymphoid tissue. Histopathology, 1987:11:445-462.
12. Aisenberg, A.C. Coherentview of non-Hodgkin’s lymphoma. 3. Clin. Oncol., 1995; 13:2656-2675.
13. Freeman, C., Berg, J.W. and Cutler, S.J. Occurrence and prognosis of extranodal lymphomas. Cancer, 1 972;29 :252-260.
14. Nime, F.A., Cooper, H.S. and Eggleston, J.C. Primary malignant lymphomas of the salivary glands. Cancer, 1 976;37:906-912.
15. Shikhani, A., Samara, M, Allam, C. Primary lymphoma in the salivary glands. Report of five cases and review of the literature. Laryngoscope, 1987;97: 1438-42.
16. Batakis, J.G. Tumors of the major salivary glands. In: Tumors of the head and neck; 2nd edition, Baltimore, The Williams and Wilkins Company, Baltimore, 1979, pp. 1-75.
17. Salkar, R.G., Salkar, H.R., Dharmadhikari, A. etat. Non- Hodgkin’s lymphoma presenting as Mikulicz syndrome (letter). J. Assoc. Physicians, India, 1 989;37:473-4.
18. Koike, S., Ogawa, T.,Uno, K. etal. A case of non-Hodgkin’s lymphomamanifesting an eyelid tumor as a major symptom. Gan No. Rinsho, 1987;33:283-6.
19. Singer, L,Mclaughlin, A. and Morris, J. Appearance ofGa-67 citrate scaning in a patient with Mikulicz syndrome associated with non-Hodgkin’s lymphoma. A case report. Clin. Nuci. Med., 1984;9(5):283-5.
20. Logan, TE., McDonald, J.S, and Alpert, B. Clinicopathological conference. Case 19, part 2 Mlkulicz syndrome secondary to lymphosarcoma. J. Oral. Surg., I 977;35:719-20.
21. Habibullah, CM. Case of malignant lymphoma presenting as Mikulicz syndrome. J. Assoc. Physicians, India, 1969;17:667-9.

Journal of the Pakistan Medical Association has agreed to receive and publish manuscripts in accordance with the principles of the following committees: